Breast carcinomas with hyperprolactinemia at the time of diagnosis-clinico-biological association

摘要

Aim: To analyse association between preoperative hyperprolactinemia serum levels and clinical and biological features of breast tumors. Methods: Serum levels of prolactin were measured in 253 women with invasive breast cancer. Clinical and biological parameters analysed were age, size, lymph node involvement, distant metastasis and immunohistochemical expression of estrogen receptor, progesterone receptor, androgen receptor, bcl-2, p53 and Ki67. Results: In ductal carcinomas hyperprolactinemia were associated with high age (p=0.017), and with bcl-2 + + + expression (p=0.017). Furthermore, serum prolactin values were significantly higher in bcl-2 +++ cases vs negative (p=0.029); the same happened when we considered the positivity threshold of 25ng/mL (p=0.015). Conclusion: Is possible to detect in 6% of infiltrating ductal breast carcinomas hyperprolactinemia (>25ng/mL), being associated only with increasing age, but not with other clinical or biological factors; and 2) the most surprising data was the association between prolactinemia (qualitative (>25ng/mL) and quantitative) and intense bcl-2 tissue expression, which suggests that, probably, this (prolactinemia) is not a sign of worse prognosis and evolution.